AVADEL PHARMA Stock Price (NASDAQ:AVDL)

Add to My Stocks
$10.75 $0.48 (4.67%) AVDL stock closing price Feb 27, 2017 (Closing)
YOUR DAILY UPDATE ON
AVDL
AVADEL PHARMA
28 FEB 2017
amigobulls logo
AVDL hand_up
AVDL vs S&P 500
Closing Price: Feb 27, 2017
AVDL
$10.75 ( 4.67%)
S&P 500
2369.8 ( 0.1%)
AVDL
52 Week Price Range
1 Year Return: 23.14%
Q3 Growth*
Poor
Profitable ?
Yes
net image
2016 Q3 Net Profit
18.2%
PE Valuation
Expensive*
home image
Rating
AVDL AVERAGE
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

AVADEL PHARMA Snapshot Video

4 5 2

AVDL Stock Details

Prev Close* : $10.27
Market Cap:
$423.55M
Day Low: $10.29
52 Week Low: $7.56
Open: $10.29
Volume: 145446
Day High: $10.87
52 Week High: $15.45
Dividend:
N/A

Latest Stock Market News

Latest Articles

AVADEL PHARMA News - From Partners

AVDL Stockcharts

View AVDL PE ratio, PS ratio stocks charts and compare with peers.
AVDL Chart
Note: Compare AVADEL PHARMA stock price history with the index and industry peers.

AVADEL PHARMA Valuation

PE ratio
(price earnings ratio)
18.53
PS ratio (
price to sales ratio
)
2.94
PB ratio (
price to book ratio
)
9.8

AVADEL PHARMA Returns

ROE
(return on equity)
61%

AVADEL PHARMA Financial Ratios

Asset Turnover
0.52
Receivables Turnover
20.31
Debt to Equity
0.03

AVDL Industry Peers

Company Price Change (%)
Collegium Pharma (COLL)140.04 (0.28%)
Karyopharm Therapeutics (KPTI)11.131.03 (10.2%)
Foamix (FOMX)9.720.12 (1.25%)
Akebia Therapeutics (AKBA)10.150.21 (2.11%)
Merck (MRK)65.850.31 (0.47%)
Acura Pharma (ACUR)0.50.01 (1.96%)
Depomed (DEPO)16.580.26 (1.59%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
La Jolla Pharma (LJPC)35.1215.25 (76.75%)
ImmunoGen (IMGN)3.280.57 (21.03%)
Karyopharm Therapeutics (KPTI)11.131.03 (10.2%)
Arrowhead Pharma (ARWR)2.360.21 (9.77%)
Rigel Pharma (RIGL)2.520.22 (9.57%)
Heron Therapeutics (HRTX)15.151.25 (8.99%)
Xencor (XNCR)24.771.97 (8.64%)
Top gainers from Medical-Drugs industry
* As of Feb 28, 2017
CompanyPriceChange (%)
Merus Labs International (MSLI)0.840.02 (2.33%)
Lannett Co (LCI)22.60.3 (1.31%)
Redhill Biopharma (RDHL)9.320.11 (1.17%)
MADRIGAL PHARMA (MDGL)15.60.05 (0.32%)
Grifols (GRFS)17.480.02 (0.11%)
Zoetis (ZTS)53.830.05 (0.09%)
Top losers from Medical-Drugs industry
* As of Feb 28, 2017

AVADEL PHARMA Financial Statements

income statement20152014201320122011
Net Sales Or Revenues173.2M14.77M22.44M26.1M32.6M
Net Income40.65M-88.92M-42.92M-3.22M-8.77M
Total Operating Expense90.82M32.98M39.98M40.26M35.89M
view AVADEL PHARMA income statement
balance sheet20152014201320122011
Total Assets214.97M174.2M116.25M117.31M69.4M
Total Liabilities147.11M149.31M125.76M86.8M39.6M
Shareholders Equity67.86M24.89M-9.51M30.5M29.79M
view AVADEL PHARMA balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-4.81M--1.69M-8.69M-4.39M
Net Cash From (Used By) Operating Activities84.29M-10.61M-20.67M-23.13M-10.32M
Increase (Decrease) In Prop Plant And Equipment-1.62M-1.72M-0.02M-1M-1.71M
view AVADEL PHARMA cashflow statement

AVADEL PHARMA Stock Message Board